- Home
- RFL vs IPA Comparison
RFL vs IPA Comparison
Compare RFL & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- IPA
- Stock Information
- Founded
- RFL 2017
- IPA 1983
- Country
- RFL United States
- IPA United States
- Employees
- RFL N/A
- IPA N/A
- Industry
- RFL Real Estate
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- RFL Finance
- IPA Health Care
- Exchange
- RFL Nasdaq
- IPA Nasdaq
- Market Cap
- RFL 48.4M
- IPA 46.0M
- IPO Year
- RFL N/A
- IPA 2017
- Fundamental
- Price
- RFL $1.66
- IPA $1.11
- Analyst Decision
- RFL
- IPA Strong Buy
- Analyst Count
- RFL 0
- IPA 2
- Target Price
- RFL N/A
- IPA $4.00
- AVG Volume (30 Days)
- RFL 450.8K
- IPA 4.9M
- Earning Date
- RFL 06-11-2025
- IPA 07-28-2025
- Dividend Yield
- RFL N/A
- IPA N/A
- EPS Growth
- RFL N/A
- IPA N/A
- EPS
- RFL N/A
- IPA N/A
- Revenue
- RFL $732,000.00
- IPA $16,581,105.00
- Revenue This Year
- RFL N/A
- IPA $4.67
- Revenue Next Year
- RFL N/A
- IPA $14.15
- P/E Ratio
- RFL N/A
- IPA N/A
- Revenue Growth
- RFL 35.56
- IPA 1.34
- 52 Week Low
- RFL $1.27
- IPA $0.27
- 52 Week High
- RFL $3.19
- IPA $1.16
- Technical
- Relative Strength Index (RSI)
- RFL 46.95
- IPA 78.39
- Support Level
- RFL $1.41
- IPA $0.82
- Resistance Level
- RFL $1.70
- IPA $1.04
- Average True Range (ATR)
- RFL 0.28
- IPA 0.14
- MACD
- RFL -0.05
- IPA 0.03
- Stochastic Oscillator
- RFL 11.63
- IPA 93.75
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.